Attendees at ObesityWeek® 2022 listened with much excitement to the results of the STEP TEENS phase 3 trial of once-weekly subcutaneous semaglutide 2.4 mg ...
In a recent study, adolescents, who received weekly doses of semaglutide 2.4 mg alongside lifestyle intervention, saw a significantly greater reduction in ...
Semaglutide users also more likely to experience weight loss, retrospective study suggests.
A drug called semaglutide, which is approved for adults with obesity or overweight, also helps adolescents shed pounds and have healthier hearts,
Semaglutide — the medication in the blockbuster anti-obesity drug Wegovy — plus lifestyle intervention led to a “substantial reduction” in the body mass ...
Though another drug approved for use in adolescents with obesity exists, semaglutide is the “most highly effective anti-obesity medication for teens,” Kelly ...
Semaglutide use in adolescents with obesity resulted in significant reductions in body mass index vs lifestyle intervention alone.